Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report.

Authors:
Yan C; Zhao F; Gao S; Liu X; Yu T and 3 more

Journal:
BMC Ophthalmol

Publication Year: 2023

DOI:
10.1186/s12886-023-03211-w

PMCID:
PMC10683125

PMID:
38012561

Journal Information

Full Title: BMC Ophthalmol

Abbreviation: BMC Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study was approved by Ethics Review Committee of The Third People’s Hospital of Dalian(2023-108-001). Consent for publicationWritten informed consent was obtained from the patient’s parent. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding Financial support from Hunan Provincial Science and Technology Innovation Program Project (2020SK50105), Liaoning Provincial Science and Technology Program Project (2022JH1/10800071), and The Third People’s Hospital of Dalian Research Start-up Fund (2021ky006)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025